164 related articles for article (PubMed ID: 35410957)
1. Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review.
Dawson AG; Kutywayo K; Mohammed SB; Fennell DA; Nakas A
Thorax; 2023 Apr; 78(4):409-417. PubMed ID: 35410957
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma.
van Ruth S; Baas P; Haas RL; Rutgers EJ; Verwaal VJ; Zoetmulder FA
Ann Surg Oncol; 2003 Mar; 10(2):176-82. PubMed ID: 12620914
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.
Migliore M; Calvo D; Criscione A; Viola C; Privitera G; Spatola C; Parra HS; Palmucci S; Ciancio N; Caltabiano R; Di Maria G
Future Oncol; 2015; 11(2 Suppl):47-52. PubMed ID: 25662329
[TBL] [Abstract][Full Text] [Related]
6. Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
Migliore M; Calvo D; Criscione A; Palmucci S; Fuccio Sanzà G; Caltabiano R; Spatola C; Privitera G; Aiello MM; Parra HS; Ciancio N; Di Maria G
Future Oncol; 2015; 11(24 Suppl):19-22. PubMed ID: 26638918
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
[TBL] [Abstract][Full Text] [Related]
8. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.
Hod T; Freedberg KJ; Motwani SS; Chen M; Frendl G; Leaf DE; Gupta S; Mothi SS; Richards WG; Bueno R; Waikar SS
J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1510-1518. PubMed ID: 32631662
[TBL] [Abstract][Full Text] [Related]
10. Salvage debulking surgery and hyperthermic intrathoracic chemotherapy for massive recurrent mesothelioma in the mediastinum.
Poon SS; Alberti C; Nardini M; Migliore M
Interact Cardiovasc Thorac Surg; 2022 Jun; 35(1):. PubMed ID: 35218349
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive Thoracic Surgery Combined with Hyperthermic Chemoperfusion for Pleural Malignancies: A Single-Center Experience.
Klotz LV; Gruenewald C; Bulut EL; Eichhorn F; Thomas M; Shah R; Kriegsmann M; Schmidt W; Kofler O; Winter H; Eichhorn ME
Respiration; 2021; 100(12):1165-1173. PubMed ID: 34384085
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts.
Chu NQ; Liu R; Colby A; de Forcrand C; Padera RF; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2020 Sep; 160(3):e159-e168. PubMed ID: 32044093
[TBL] [Abstract][Full Text] [Related]
13. A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study Protocol.
Shah R; Klotz LV; Chung I; Feißt M; Schneider MA; Riedel J; Bischoff H; Eichhorn ME; Thomas M
Clin Lung Cancer; 2021 Mar; 22(2):142-146. PubMed ID: 33158765
[TBL] [Abstract][Full Text] [Related]
14. Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience.
Ambrogi MC; Bertoglio P; Aprile V; Chella A; Korasidis S; Fontanini G; Fanucchi O; Lucchi M; Mussi A
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1857-1866.e2. PubMed ID: 29191688
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma.
van Ruth S; van Tellingen O; Korse CM; Verwaal VJ; Zoetmulder FA
Anticancer Drugs; 2003 Jan; 14(1):57-65. PubMed ID: 12544259
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic intraoperative intrapleural chemotherapy and surgical cytoreduction as part of multimodal treatment of malignant pleural mesothelioma - case report M. Szkorupa1, D. Klos1, J. Chudacek1, J. Hanuliak1, M. Stasek1, O. Fischer2, R. Lemstrova3.
Chemotherapy HII; Report SCAPOMTOMPM; Szkorupa M; Klos D; Chudacek J; Hanuliak J; Stasek M; Fischer O; Lemstrová R
Rozhl Chir; 2020; 99(10):456-461. PubMed ID: 33242963
[TBL] [Abstract][Full Text] [Related]
17. [Hyperthermic intrathoracic chemotherapy in thoracic surgery].
Hofmann HS; Ried M
Chirurg; 2019 Aug; 90(8):681-694. PubMed ID: 31218434
[TBL] [Abstract][Full Text] [Related]
18. Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis.
Zhao ZY; Zhao SS; Ren M; Liu ZL; Li Z; Yang L
Oncotarget; 2017 Nov; 8(59):100640-100647. PubMed ID: 29246008
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial.
de Boer NL; van Kooten JP; Burger JWA; Verhoef C; Aerts JGJV; Madsen EVE
BMJ Open; 2019 May; 9(5):e026779. PubMed ID: 31092657
[TBL] [Abstract][Full Text] [Related]
20. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
